Scinovex
article Open AccessTop 1% cited

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Clinical Infectious Diseases · 2015 · Vol. 62(4) · pp. e1–e50
Peter G. PappasCarol A. KauffmanDavid R. AndesCornelius J. ClancyKieren A. MarrLuis Ostrosky‐ZeichnerAnnette C. ReboliMindy G. SchusterJosé A. VázquezThomas J. WalshTheoklis E. ZaoutisJack D. Sobel

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

MeSH terms

AnimalsAntifungal AgentsCandidiasisHumans

Funding

  • National Institutes of Health
  • National Institute of Dental and Craniofacial Research
Citations
3,917
FWCI
139.61
field-weighted impact
References
576
Percentile
100%
vs. same field & year
Citations per year
Cited by
Untitled
International Journal of Applied Research · 2021 · 0 citations
Candida sp. Infections in Patients with Diabetes Mellitus
Journal of Clinical Medicine · 2019 · 297 citations
The global problem of antifungal resistance: prevalence, mechanisms, and management
The Lancet Infectious Diseases · 2017 · 1,008 citations
Changes in the epidemiological landscape of invasive candidiasis
Journal of Antimicrobial Chemotherapy · 2017 · 528 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.